MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0003007
KRS Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.79 Cr
▲ 60% YoY
Net profit · FY 2025
₹16.13 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹3.27 Cr
EBITDA margin 6%
Authorised capital
₹8.46 Cr
Registered with MCA
Paid-up capital
₹6.73 Cr
Issued & subscribed
Open charges
₹22.51 Cr
Satisfied ₹9.55 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
55
Provident fund records
About KRS Pharmaceuticals Private Limited
Data last updated:
KRS Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 12 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2000PTC035234. Its GSTIN is 36AABCK4657M1Z4 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹8.46 Cr and a paid-up capital of ₹6.73 Cr. It is led by directors including Lakshmana Swamy Balusu (Managing Director) and Narendra Balusu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.44 Co – Operative Industrial Estate Gandhi Nagar Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.79 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹16.13 Lakh (net margin 0.3%) and EBITDA of ₹3.27 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over five years.
The company has about 55 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: KRS Pharmaceuticals. As per MCA filings, the company has open charges of ₹22.51 Cr and satisfied charges of ₹9.55 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending. The company has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Tradeco Pharmaceuticals Private Limited with revenue of ₹54.98 Cr.
KRS Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0003007). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krspharma.com.
Company Details of KRS Pharmaceuticals Private Limited
CIN U24239TG2000PTC035234
Registration Number 035234
Incorporation Date 12 September 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0003007
CIN History of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2000PTC035234. The current CIN is U24239TG2000PTC035234, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2000PTC035234 | Current |
| U24239AP2000PTC035234 | Previous |
Key People
Lakshmana Swamy Balusu Managing Director Narendra Balusu Director Sai Phani Teja Balusu Director Recognitions & Rankings of KRS Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.44 Co – Operative Industrial Estate Gandhi Nagar Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, API Manufacturers
Comprehensive company report
KRS Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals operates one associated brand: KRS Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures chemicals and intermediates while providing contract research services for the pharmaceutical industry. | krspharma.com |
Business Activity of KRS Pharmaceuticals Private Limited
The main business activity of KRS Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of KRS Pharmaceuticals Private Limited FY 2025 filings available
KRS Pharmaceuticals Private Limited reported revenue of ₹54.79 Cr (up 60% YoY) for FY 2025.
Revenue · FY 2025
₹54.79 Cr ▲ 60%
Net profit · FY 2025
₹16.13 Lakh margin 0.3%
EBITDA · FY 2025
₹3.27 Cr margin 6%
Compounded Annual Growth Rate (CAGR) of KRS Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 60%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 19%
5 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 60% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of KRS Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.27 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of KRS Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of KRS Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmana Swamy Balusu | Managing Director | 12 Sep 2000 | 26 Years 1 Months | Current |
| Narendra Balusu | Director | 27 Aug 2004 | 22 Years 1 Months | Current |
| Sai Phani Teja Balusu | Director | 13 Oct 2021 | 5 Years 0 Months | Current |
| Koneru Chiranjivee Rammohan Rao | Director | 02 Nov 2009 | 16 Years 11 Months | Current |
Peer Comparison of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tradeco Pharmaceuticals Private Limited | ₹54.98 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Kolkata, West Bengal, India |
| Prahem Laboratories LLP | ₹54.97 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| G Amphray Pharmaceuticals Private Limited | ₹54.89 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Kamla Lifesciences Limited | ₹54.89 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Boisar, Maharashtra, India |
| Glacier Pharmaceuticals Private Limited | ₹54.81 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Amaravati, Maharashtra, India |
| KRS Pharmaceuticals Private Limited this company | ₹54.79 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Hyderabad, Telangana, India |
| Zandra Life Sciences Private Limited | ₹54.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Trimurti Distributors Private Limited | ₹54.27 Cr (FY 2025) | •••• | •••• | 1652.0% | •••• | Jalgaon, Maharashtra, India |
| Vim Meditech Private Limited | ₹53.98 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Vital Healthcare Private Limited | ₹53.97 Cr (FY 2024) | •••• | •••• | 221.0% | •••• | Mumbai, Maharashtra, India |
| Akriti Pharmaceuticals Private Limited | ₹53.84 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below KRS Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited is audited by DARAPANENIANDCO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DARAPANENIANDCO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of KRS Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of KRS Pharmaceuticals Private Limited
Open charges
₹22.51 Cr
Satisfied charges
₹9.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2023 | Others | ₹4.98 Cr | Open |
| 27 Jun 2023 | Others | ₹9.1 Cr | Open |
| 29 Sep 2020 | Axis Bank Limited | ₹14.3 Lakh | Open |
| 22 Feb 2018 | Others | ₹8.29 Cr | Open |
| 12 Jan 2009 | State Bank of India | ₹8.56 Cr | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021.
Total deals
8
Funding rounds
4
Secondary share transfers
4
Disclosed funding
₹7.03 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Funding round | ₹69 Lakh | Investors: 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Pink Estates Pvt Ltd , 3 individuals |
| Mar 2012 | Funding round | ₹3.93 Cr | Investors: Ocean Pharmacoat Private Limited , 3 individuals |
| Mar 2010 | Funding round | ₹1.67 Cr | Investors: Pink Estates Pvt Ltd , 3 individuals |
Premium access
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited has 7 court cases on record: 5 filed by KRS Pharmaceuticals, 1 filed against it, 1 where it is another party. 1 case is pending and 6 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
7
Filed by the company
5
Filed against the company
1
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Assistant Commissioner of Central Tax | Pending |
| High Court of Andhra Pradesh | Writ petition | Company is another party | Disposed |
| District court, Rangareddy, Telangana | Execution petition | Filed against the company by an individual | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (AS) | Filed by the company against an individual | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against Central Power Distribution Company of A.P. Ltd | Disposed |
Premium access
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited has a workforce of 55 employees as of Apr 05, 2024.
Employee count
55
Active EPFO establishments
1
Employee growth
-17.91%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals Private Limited has 5 board changes on record since 2000: 4 appointments and 1 cessation. The latest: Sai Phani Teja Balusu was appointed as Director on 13 Oct 2021.
AGM
Krs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Krs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 9.10 Cr registered on 27 Jun 2023 with Charge ID 100766026 was modified on 31 Jan 2025.
Charges
A charge with Others amounted to Rs. 4.98 Cr with Charge ID 100872415 was registered on 29 Dec 2023.
Charges
A charge with Others amounted to Rs. 9.10 Cr with Charge ID 100766026 was registered on 27 Jun 2023.
Appointed
Sai Phani Teja Balusu was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.14 Cr with Charge ID 100475355 was registered on 29 Sep 2020.
Charges
A charge with Others of Rs. 8.29 Cr registered on 22 Feb 2018 with Charge ID 100172579 was modified on 24 Dec 2019.
Charges
A charge registered on 12 Jan 2009 via Charge ID 10138147 with State Bank Of India was fully satisfied on 23 Apr 2018.
Charges
A charge with Others amounted to Rs. 8.29 Cr with Charge ID 100172579 was registered on 22 Feb 2018.
Charges
A charge with State Bank Of India of Rs. 8.56 Cr registered on 12 Jan 2009 with Charge ID 10138147 was modified on 07 Nov 2016.
Appointed
Koneru Chiranjivee Rammohan Rao was appointed as Director.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for KRS Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by KRS Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of KRS Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCK4657M1Z4 | Telangana | Active | 01 Jul 2017 |
| 37AABCK4657M1Z2 | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of KRS Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KRS Pharmaceuticals Private Limited
KRS Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 12 September 2000 (26+ years old) and is registered under CIN U24239TG2000PTC035234.
KRS Pharmaceuticals reported revenue of ₹54.79 Cr for FY 2025 (up 60% YoY).
KRS Pharmaceuticals has 4 current directors:
- Lakshmana Swamy Balusu - Managing Director
- Narendra Balusu - Director
- Sai Phani Teja Balusu - Director
- Koneru Chiranjivee Rammohan Rao - Director
KRS Pharmaceuticals reported a net profit of ₹16.13 Lakh (net margin 0.3%) and EBITDA of ₹3.27 Cr (EBITDA margin 6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of KRS Pharmaceuticals is 1% over five years. In the latest year (FY 2025) revenue rose 60%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of KRS Pharmaceuticals is 36AABCK4657M1Z4, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCK4657M1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of KRS Pharmaceuticals is U24239TG2000PTC035234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KRS Pharmaceuticals has 7 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
KRS Pharmaceuticals was incorporated on 12 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
KRS Pharmaceuticals has 8 deals on record (4 funding rounds, 4 secondary share transfers), with disclosed funding of ₹7.03 Cr; the latest was in March 2021.
The peers of KRS Pharmaceuticals by revenue are Tradeco Pharmaceuticals Private Limited, Prahem Laboratories LLP, G Amphray Pharmaceuticals Private Limited, Kamla Lifesciences Limited, Glacier Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).